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I-I 1063 105 RlborymSS to Consrrvsd Human-Porcine PCNA Reduce Irkstent Restsnoris In a Porcine Model 
A Fnmerman. l-L Honda. R. Makkar, N. Et@or. P. Welch. J. Btuber. 
F. 11tvack. CedarsS!nar Medkut Centor, Las Angeles. Caldornta. USA 
We destg”ed chtmenc DNA*RNA hammerhead nbozymr~s (RZ) @conserved 
mRNA for p~rw=@ atnd human PCNA. In vkra studios included Rz clawa~e 
and wum etablllty. In vIvo we assessed Rb ctffect on DNA synltrests and 
prOkferatlon of cu!tumd parcine and human vasculat SM cells, We then 
ahMe@, in a rtenl modal. 18 non lipamic, adull m (2Q coronaries) treated 
by local in- at 180 ~tgm at the angcoplasty srC of ewrwr; 1) scrambbd 
w @3ntrol (SW). 2) RZ I(, PCNA of 9) stent Sl~ne (SE) (8 wf8fltNg/group). 
Al 5 w@&s angleQraphy, sacrifE@ and hirtomorphometry were done. 
F?@@&s: RZ c@verl~%Y% mRNA and pers~stad m sewrn up lo 5 mm= 
UtQa- DNA l~Von!cell pmllferalm were boih ~rukcanrly reduced. 
@antilalivg coconsry an~@~raphy (% MC@ steno&) and hisMnorphomet. 
ric itnalvsls (h Area slenos~s) data are. 
Corwlusrons AzsIo PCNAare brcta~~%~nV actwe m-wtro and ~-VIM. They 
marltedly reduce angtographtc and htstomOrp?tomelnc m-stent stenosis m a 
pmcme “todel 
I 1063 106 &tenovirus-rnadiatad Gene Transtsr of Recombinsnt Tissue Factor Pathway lnhibftor in 
Vitro and In Vhro 
P. Zotdhelyt. J M. b&Nan. H.S. Shelat. PM. DMard. T-C Wun. T Reese, 
J.T. ~llerson Texas Heart Imtrhrfe. Horrsion TX, USA 
Local upregulation ol tissue (actor contnbutas to the thmmbogen~crly ol the 
alherusclerotic wall. To assess wbelher Ihe gene enco&tg human 11ssue 
tactor pathway mhtbttor (TFPI) can be fransferred to vascular cells and the 
atherusclemtr vessel wall. we have constructed a reccmbrnant adenovxus 
(Ad) canymg the cDNA eocodmg TFPI TFPI was measured by ELISA in the 
condihoned n&rum of dog vascular smooth muscle cells (VSMC) mfected 
with Ad.lFPI at a mumpl!aty of intectKm (MOIt of 500. Secretton or TFPI 
(“@lo5 cells24 h) was 1098 2 2g2 (mean z SO) on day 2.6145 I 1125 on 
day 4 (peak). and 626 i i7 on day 7. Four days after mtectton vvllh Ad TFPI 
al MQI 20. 100. 200. and 500. VSMC produced. respectively. 61 * 51. 197 
: 205,405 I 387 and 6145 x 1125 ng TFPl/106 cells/24 h. whtch was on 
a molar basis. -,%I% actwe In mhlbnmg hssue (actocfactor Vlla m a factor 
X activation assay Control Ad (no lransgene) d!d not mduca expresston 01 
TFPt m dog VSMC. NO TFPI was delected by ELISA (detechon threshold 
0 4 ng’mL) in the condtt~oned medium ot human VSMC. but was 347 : 80 
ngil@ cells124 h three days atter to&bon with Ad.TFPI al MOI 100. TFPI 
was vtsuallzed by rmmunohts1ochemrstry in Ad.TFPl-infected cultured dog 
VSMC and tn the balloon-Injured femoral artery of a hypercholestemlermc dog 
mfected 4 days before sacnkce by local dwell with Ad.TFPI (6 . 10” ptuimL). 
TFPI was observed by immunoh~s~ochemrstry m sever+ athemsclerotx 
caroled artenes 01 Watanabe rabbrls mfected al the l!me ol balloon m]uty with 
Ad.TFPI (but not control VINS) al 1 \ 1O’O phumL. Our hndtngs show that 
adenovuus-medla&sl gene transler ot TFPI can achteve expressron 01 TFPI 
wIthIn the alherosclerotic vessel wall and Indicates the patenttal of local TFPI 
gene transfer to prevent lhrombin generation and thrombosis at the s!te of 
balloon mtury to athemsclembc plaques. 
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I 1064 1 Thermolabile Methylenetetrahydrofolate Reductase in Coronary Artery Disease 
F.F. Willems’. L.E.J. Kluijtmans' , J.P. Kaslelein’. J. Lindemans’. 
G.H.J. Boer;‘, A.V.G. 13ruschke4. F.M.F. Trijbels’. G.J.M. Boerma’. 
W.W.J. Jukemad. F.W.A. Verheugt’. H.J. Blorn’. ‘UniVeJSity h@OSPital 
N/jmegen. The NeNterlands; 2Academical Medical Ceflbe. The 
Nether/an&; 3univers;ry Hospital Rotter&m. The Nefherlands: 4 University 
Hospital Leiden. The Netherlands 
Mild hyperhomocystememia is an independent and graded nsk factor for 
CO~ONUY art~v disease (CAR). and nu~y result from enwmnmarnai and 
horedMy factors A rccemly dcteclcd 677&T lransrtlon tn the memyle~te. 
tfehydmtQlalO reductase (MTHFR) gene has been associated with clwataq 
plasma homocVstt%ne Concentrations Wo assessed lhe heque”cy 01 RNB~ 
CommQn mulatlon tn 735 mate palants tram the atnfh REGRESS (Aegres- 
soon Omw!h Evaluatton Stakn Study) study and in 1.2sO Putch contres. nts 
frequency at thb hornozygotrs (+!c) mulaMn was Q.$?% aff#arg (CAR) pa. 
bents vewu~ 8.5% am~nong contrclr) (QR 1.21 [!K% Cl: Q.t?7=l,I]). Ptaasma 
homc~Isln@ conc@nlml~ were srign&anlty @ava@d M both (+I+) and 
(*I-) mdivlduals coompprqd wifh (--I--) subtack For B reliaple ewrnatrw, ot 
the npik ot the (+/+I g@nolype m CAD. we peflomwtd a mela-analywa MI a 
EBIle cQ”llQ( StudlQpi. I” thlr an@YM the (+I*) gw~~lype Was Precient I!I 
(12 1%) out ot 2.476 palIrma and in 257 (10.4%) oul ol2.461 co.“trotl Th18 
rerrulwd In a signtllCa”l OR of 1.22 [%% Cl! l.Ql-1.47j. de~ns?raVng lhal 
(he (+I+) genQ&pe 1s a modaH but siQnllic4nl Q~VV%C flsb facV?r for CAD, 
whsh 18 likely m&tlaled by folate @tabs. 
-1 064 2 E-Sektln Qsnotypss In Patients With Documented 
Sevsrs Coronary Artsry Diseane 
M. Rauchhau6. S 0. Anker. K Handschug. W Techmann. C. Qlaetler oepr 
ot C+8f@o@& d Smn Luther Unrvenrty ffalle. Germaw; Catirac A@@cra 
NffLl LOndofl. UK 
BRckground. The relevance of the E-selectIn genofipeac as an mdtcalor 01 
alk?ro&xlerolrc nsk 19 under debate. We studled Ihe gemype frequency of the 
12%senr!dargmme polymorphism at the EGF-kke domain of lhe E.aelecbn m 
64 co%secut~ve patrents wtM conmary artery disease (CAD, 76% males) who 
underwent corunafy angropIasty and In 102 control rubpxts (57% maIes) 
w~lhoul clmrcal ewdence of CAD. 
Aferh&s The E-selectm polymorphrsm was anatysed by PCA. rtngte 
strand contomralron poiymorphlsm analysis and drrecl sequencmg ot PCR 
product!%. 
ffesults: The hequencres ot ma argmme!argmtne. argtni~nne and 
senne:senna genolypes were 0% 9%. and 91% (l+esselMseasa. n ii 
11). g%. 30%. and 70”b (2-vesseldisease. n = 27) and 6%. 25%. and 
75% (3-vessel disease. n = 16) rn mese groups (p = 0.0008. tar uttergroup 
differences) and 2%. 14% and 64% III the control subpzcts (p = 0.06, controls 
vs all patients). There was an excess in the argmine/senne genotype among 
patlents wrth multnresscl disease vs pahents wllh luessal d+SeaSe (28% vs 
9%. p = 0.0005) and vs conlrol sublects (26% vx 14’.. p = 0.02) as well as in 
one subgroup at 12 pattents wrlh a paatlve family history tar CAD m contrast 
to the rernalnrng 42 pabents (42% vs 19”~. p = 0.03) 
Concrus~on: me argmme/senne genotype was s~gn~t~canlly related to 
mulhvessel CAD and could help to predrct the rndnndual nsk ol developmen( 
01 severe mamtestahon of coronary adew disease 
Iros4-3 Oxidative Stress 1s Genetically Influenced by the 
’ Haptoglobin Potymorphlsm 
M.R. Langlos. J R. Delanghe. DA Dupraz. M.L De Buyzere. UnntersrTy 
Hospftar Germ?. Be/grum 
Backgrourr& Haptoglobm (Hp) IS a hemoglobm-btndlng plasma protern wtth 
three geneln. phenotypes- Hp l-1. Hp 2-1, Hp 2-2. The pmteln IS an antIOR- 
xianl prolearng agarmt the hemoglobi~mndnvan ox~dalwe stress. As tho 
Hp 2-2 type IS an independent “sk factor m coronary artery disease and pa- 
npheral artenal occlusnre disease. we investrgated Ihe rmndrrven oxidabw 
stress accordrng to Hp phenolypo. 
Melhods The lip type was detormmed usmg starch gel electrophores~s 
m serum samples horn 205 healthy Caucasians (108 malo% 97 fCmakB) 
Iron metabol!sm and wlamm C anboxldant sta1us were studled by measunng 
serum Iron. transtcrnn (Trtt saturation. fernlm. and vrlamtn C levels. 
Ho 1.1 ,n = 35) Ho 2-t ,n z 98) Ho 2.2 (n D 72) ANOVA Pvah~o) 
Haptoglabm lg.1) t 26 f 0 43 1 08 f 0 50 oElr042 0005 
iron trrmOrlt 166:61 IP6:77 213:86 0 o-1 
Tli-sa!uratlon I’s, 27 t 9 30 : IO 35 : 12 003 
Fernr~n I,@ 51 : 35 64 : J?, 85 I 59 ouu3 
Vllamln c (ilmol I, 57 7 17 7 60.2. 193 465. 139 0001 
Data are mean 2 SD. 
Resulfs: The serum Hp concenlrahons correspond ro the type-related 
reference values In Caucasians. showmg lowest levels In Hp 2-2 subiects. 
The Hp 2-2 type is assocxated with higher mm. hansh?mn SahIrahOn. and 
territtn levels and with low vitamin C concenl5bOnS. 
Conc~us;on: Hp 2-2 subjects have a lower hemoglobm-btnding Capaaty 
and hence a htgher degree of heme iron arXXmUlatlOn. ThlS iKIn excels On Its 
turn induces a” oxidative vitamin C depletion. Our resutfs are In agreement 
with thy clmrA association of Ho 2-Z mth atherosclerosis. and lurther Support 
lha nood tor cllnical lrlnls wllh ontioxldflnla according lo Iho Hp pnonatypo 01 
Iha pallonls. 
1064-r) Reduced Response to Activated Proteln C and 
InherIted Factor V Mls-aenee Mutatlon In Patients 
With a History of Acute Myocardlal ntarctlon or 
Eeesntlal Hypertenalon 
Th.K, Makrla, F?Q. Kmapl, A.N. Halxlxnchflrlsa, AI% Glalerakl, 
G.P. Anaatnatnd\s. N.V. Dnttnnta, V.E. Vottans, C.D. Panag\otopoulou. 
T.E. Mandalakl, M.K. Kyrlflkldls. Cnti/~?/ag,v OPpf. - 2nd I%?@ R~-~anmo% 
Lab, LAIKO OFn. mp. PI Alhens, @Qa6% 
Bn&kgr~~mff: lwl~tnnon 1~ RG~RI~~ prolain 6 (APCI which rnaulla Imm 
varloua tactara, lncludtng n mutallon In lha gana for fiaagulanl lnclor V (FV), 
hns bean dnmanslrnlad na A rtak tnclor tar vanoun lhmmbaale. Maraovar, 
lnhntltod lacfar V mln.aanna point mutnllon, FV Q!XIO haa racontly baan 
tdantltlad aa a mn\or QGUR~ ot fnmlllnl vanoua thromboslrr: but thorn la tlttla 
lnlonnnllon about lhalr aaaacmllan wllh artsrlnl thramhosls Thea nludy wns 
doslgnod lo Invaallgala both. raapanaa lo APC nnd Iha factor V mulnllan 
Irlcldanco In Qrenk pnllanlw (plo) wllh a hlslary al naula myoonrdlnl tnlamllon 
(astabllahad oriarlnl lhrombaala) nnd pta with aRAart\II\\ hypartondon. a lqh 
rlak group tar nnarlnl Ihmmboals. 
M@lhc&?: 4R pla with a hlnlary al myo%?rdtnl inlmclton (Rrairp A), 80 
pI8 wlh a hlalory ot QRsOnltal hyparlunalan (Graup 8) and 62 flga-matchad 
control8 wllhaul nrtorlnl dlaanao (Group C) warn shldmd, Pnlionte usmg 
anllcongulnnl drugs WOM ox&dad. Rnspanno la APC wnfl dotorminod in 
daubla conlrttugod plnlalal poor plnsma. Pnllonla waro gonatypo tar Iho Arg 
506 to Qln mutallon m lha nana for cangulnnt fnotor V, 
F!&+%JII?J: The lncldenca al lhn mulollon wna XI%, 13.75% and 6% in lho 
@nupa A, R nnd C mspocllvaly. l’ho lncldonco al rmiucod mnpanao lo APC 
was 47.5% In group A vs 13% In ~mup C (p . O,gOr) nnd 36.25% In group R 
VR 13% In amup C (O.OQl . p .. O.Ot). Tho ruaponsn to nctlvated pmtain C 
(APC) expmanad ns mann vnkio i SD was 2.05 -I, 0.36 In group A vs 2.56 t 
0.49 in group C (p . 0.001) nnd 2 .I 0.18 In gmup B VR 2.58 I 0.40 In group 
c (p i aoar). 
Conckislon: Qur hndngs sugqast thnt Gmok pntlonts with R history al 
acute myo-znrdlnl lnlnml~on or ossonllnl hyporlonalon hnva n slgmlicanlly 
lncmnsod lncldonco ol both mducod msponso lo APC and lnhonlod laclor V 
mUnllon In compnnson lo Iho canlrol graup. Thoso prellmlnnry rusults rniso 
lho posalblllty Ihnl mducod msponso la APC mny bo n rlak tactor tar artonr~~ 
dlsonsa. 
1___3 1064-5 Plasma Apollpoproteln B Levels Predict Platelet-dependent Thrombosis In Patlents Wlth 
Coronary Artery Ulsease 
M Shochlor. C N 0 Morz. M Paul-Labrador, M.D. Mo\loy, 0 Corcoh. 
P.K. Shnh. S Knul. Cedars-Stnnr Medical Center. CA. USA 
Elovatod plasmn npokpoproloin (ape).R leval is n known nsk Ior atheroscta- 
rotlc CAD, howavor Its mlatlonshlp to anorial thromhosm ts unknown. We 
prospoctlvoly nssessod npo-Et and platelet-dapondonl thrombosis (PDT) in 
42 stablo CAD pattents on flsplnn and Ilpld.loworing therapy. by exposing 
porcine aorl~c media lo tholr llowtng nonanllcunguleted venous blood for 5 
mhutos at a shonr rata ot 600 sot ’ a1 37% using an ex-vivo flow cham- 
hor model Tho PDT was measured by computerized morphomotry and 
oxprossod as ,rrn:/mm of tho aomc surface 
&?slrlls: PDT was s~gnillcantly correlated wilh apo.R (Figure). PDT did 
nol cOrreQIo wrlh sorum Idal cholesterol (171 .I 26 mgldL. r = 0.3). CDL-C 
(102 t 26 mg/dL. r = 0.2). HDL-C (41 t 10 mg/dL. I = 0.1). apo A-l (126 
t 16 mg/dL, r = 0.1) or fibnnogen levels (296 f 60 mgidL. r = 0.1) (values 
are maan t SO: all p = NS) 
Concfus~on: Elevated apo-Et levels are associated with augmen~sd PDT 
in stable CAD patients despite controlled lipid levels. These findings suggest 
!hat the positive relarionship of eleva&d apo8 lo CAD may be, in part. related 
lo IIS prolhrombotlc effects 
Varlqhlllty end Aesoclatiir,le of Flbrlnogen and 
gird31ve Proteln In the Framingham Offspring 
I, Llplnska, D. Feng? P.W.F. Wilson, MA. Mlltloman, J E. Muller, 
P. Sufhorlnnd, t-t. Sllberahotr. A 8. D Agosllno. D. Levy. G.H, Tollor, Boll, 
$meI Daaconess Med/cal Cantor, Fmmhgham Heart Study, Boaron, MA, 
USA 
Fibrlnogan and C-roackva prutaln (CRP), 2 Inflammatory mnrksn that pmdtct 
cardtovaecular dtrroasa, may bs uaalul In assenaln~ shangt3s in risk. To 
determlns varlabltlty and asaoclattons avar ilma, we measured fibrinogen 
(Clausa method) and CRP (ELlSA) In 100 sub]acls (50 men. 60 women) 
tram Iha FramIngham OHsprtng Study OvQr I +yaar Interval (ago at btialtns 
wns 64 c 10 yanra). Tham wna n clean carmlatien between ba8altne and 
lallaw=up I~als (1~ figure), Enaallna LbrtnaQen G!l2 -t 8s mgfdl) incresaed 
by 6% (p 3 0,087) nnct CRP (X82 % 331 m@l) by 6% (R J NS). Them was 
nlaa a eigntftsnnt correlation batwaon bbnnogon and CRP both at baserma 
(R 9 0.6% p ‘: O.pOl) and tollow.up (R 6” 0.87, p i %aOl), supporllng a bnh 




(1 -4 m m 4 1 . (I . 1, 
Ol,*Pnm Bar&n 
Doapilo Doing acute phase ranclanls. bolh libnnogen and CRP were rel- 
ntivaly stablo over lho 4.yoar pmtod. suggesling Ihat longiludinal ctlttorcms 
may provide inslght mlo changing cnrdtovascular risk. 
1064-7 Hlgh lncldence of Chlamydla Pneumonlae In 
Atherosclerosis of Coronary Arteries With Both 
Genus and Species Spaclfic Antlsera 
E.H Hammond. J.B. Muhleslem, T.H. Hammond, J.F. Carlqulst, 
J.L. Anderson 1D.S IfoSpital. Umversrty of Utah, Salt Lake Cl@, Utah. USA 
6ackgmund: We have previously rcponcd the prevalence of chlamydlal anti- 
gen m coronary atheromas lrom symplomallc pts undergolng dm?ctlonal 
alherectomy and m control pts. In thal sludy. we used a genus.specillc an- 
tlbody (G-ab) recognizmg a chlamydral lipopolysamhande on trozen Ussue 
samples by ~mmunocytochem~stry 
A$e?bo&: We sought to extend and compare our observattons by retestmg 
those alheroma and control samples for the presence of a specros~specdic (C 
pneumomae. RR 402) antIbody (S-ab). We used frozen lissue samples and 
a slandard immunocytochemical approach (indirect immunolluorescence). 
Results: We found 911114 (79.6%) athereclomy samples from CAD pa 
tlonts were posItwe wllh G-ab and 25/47 (63.2%) were positive ~vllh S-ab 
Kappa slnlislic lor the relation between the staining resul1 seen wvilh lhese 
antibodies was 0.047. showing only marginal agreement. Conlml tissue from 
cornnary artenes of pallents dying of traumatic causes wilhoul alhemsclero- 
SIS was porllive m 0121 wllh G-ab and 2/21 (9.5ob) wllh S-ab. Patlents with 
Imnsplant-rc’sttct coronary disease had O/12 samples positwe wllh G-ab and 
l/12 (6%) with S-ab. However. the dltterences between immunoposilivily m 
atheroma versus control samples were significant for both G-ab (p = 0.001) 
and S-ab (p = 0.01) Two of three batches of S-ab caused unacceptably high 
levels of background statmng. 
Conclusions: Chlamydlal antigen prevalences detected by either G.ab 
or S-ab immunocytochemistry are Increased in coronary alheroma samples 
compared to controls. SensitivQ and reliability at G-ab IS higher, kkety due 
lo the lower avtdity 01 S-ab lo chlamydial anllgens and higher background 
starwg. The posstbibty of > 1 chlamydral specfes betng involved in athero- 
sclerosis cannot be excluded. 
k-q The Prevalence of Chlamydia Pneumonlae In 
Atherosclerotic and Normal Blood Vessels of 
Patlents Undergoing Redo and First Time Coronary 
Artery Bypass Graft Surgery 
Y. Wong. M. Thomas, P.J. Gallagher, V.T. Tsang. M.E. Ward. Southampton 
General fiospital. England 
Background: Studies have suggested inlriguingly that Chlamydia Pneumo- 
